BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24828015)

  • 1. Titration of the gap junction protein Connexin43 reduces atherogenesis.
    Morel S; Chanson M; Nguyen TD; Glass AM; Richani Sarieddine MZ; Meens MJ; Burnier L; Kwak BR; Taffet SM
    Thromb Haemost; 2014 Aug; 112(2):390-401. PubMed ID: 24828015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cluster of differentiation 43 deficiency in leukocytes leads to reduced atherosclerosis--brief report.
    Meiler S; Baumer Y; McCurdy S; Lee BH; Kitamoto S; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):309-11. PubMed ID: 25524774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.
    Herías V; Biessen EA; Beckers C; Delsing D; Liao M; Daemen MJ; Pham CC; Heeneman S
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):79-86. PubMed ID: 25395616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice.
    Takafuji Y; Hori M; Mizuno T; Harada-Shiba M
    Cardiovasc Res; 2019 May; 115(6):1041-1051. PubMed ID: 30388208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased atherosclerotic lesions in LDL receptor deficient mice with hematopoietic nuclear receptor Rev-erbα knock- down.
    Ma H; Zhong W; Jiang Y; Fontaine C; Li S; Fu J; Olkkonen VM; Staels B; Yan D
    J Am Heart Assoc; 2013 Aug; 2(4):e000235. PubMed ID: 23963755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
    van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
    Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progranulin in the hematopoietic compartment protects mice from atherosclerosis.
    Nguyen AD; Nguyen TA; Singh RK; Eberlé D; Zhang J; Abate JP; Robles A; Koliwad S; Huang EJ; Maxfield FR; Walther TC; Farese RV
    Atherosclerosis; 2018 Oct; 277():145-154. PubMed ID: 30212683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.
    Meiler S; Smeets E; Winkels H; Shami A; Pascutti MF; Nolte MA; Beckers L; Weber C; Gerdes N; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1748-52. PubMed ID: 27444204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression.
    Wezel A; Lagraauw HM; van der Velden D; de Jager SC; Quax PH; Kuiper J; Bot I
    Atherosclerosis; 2015 Aug; 241(2):289-96. PubMed ID: 26062988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation.
    de Jager SC; Bot I; Kraaijeveld AO; Korporaal SJ; Bot M; van Santbrink PJ; van Berkel TJ; Kuiper J; Biessen EA
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):e75-83. PubMed ID: 23288165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.